Quarterly Report II 15/16
September 2015 – February 2016Diamyd Medical AB (publ), Fiscal year 2015/2016Reporting period, December 1, 2015 – February 29, 2016 · Net result amounted to MSEK -4.7 (-4.1) · Net result per share amounted to SEK -0.2 (-0.2) · Cash flow from operating activities amounted to MSEK -4.4 (-3.8) · Liquid assets and short term investments amounted at the end of the period to MSEK 20.4 (25.9) First half year, September 1, 2015 – February 29, 2016 · Net result amounted to MSEK -9.0 (-10.0) · Net result per share amounted to SEK -0.4 (-0.5) · Cash flow from operating